Clinical Trial Update: A Study to Investigate the Pharmacokinetics of Tirabrutinib in Participants With Mild, Moderate, and Severe Hepatic Impairment Compared to Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics study of tirabrutinib in participants with hepatic impairment (mild to severe) compared with healthy controls to assess how liver funct…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• Tirabrutinib (tirabrutinib)

Snippet

Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: Primary Central Nervous System Lymphoma (PCNSL) | Phase 1 | Status: ACTIVE_NOT_RECRUITING